Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Surgical correction of cicatricial alopecia requires careful planning, with excision preferred over hair transplantation, and surgery should be delayed for stable conditions.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Hair transplants can be used for rare types of scarring hair loss.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Dermoscopy helps distinguish between scarring and non-scarring hair loss and accurately diagnoses hair and scalp conditions without needing hair plucking.

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

Trichoscopy is important for planning hair restoration in burn-related hair loss.

Trichoscopy is important for planning treatment of hair loss after burns.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Hair transplants can work for stable cicatricial alopecia, but success varies by condition.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

FUE hair transplantation is safe and effective for improving hair loss in children.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Potential therapeutic targets for scarring hair loss are identified.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Adding nano fat to hair transplants improves results for scar-related hair loss.

Low iron levels are linked to certain types of hair loss.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.